A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma	Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Phase 1	2026-02-05		NCT06574568

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Excyte Biopharma Ltd	7

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Zhongshan Hospital of Dalian University	Dalian	China	14
Beijing Chao-yang Hospital, Capital Medical University	Beijing	China	2
Beijing Jishuitan Hospital, Capital Medical University	Beijing	China	3
Guangxi Medical University Cancer Hospital	Nanning	China	24
Harbin Medical University Cancer Hospital	Harbin	China	102
Henan Cancer Hospital	Zhengzhou	China	57
Shandong Cancer Hospital	Jinan	China	86
Shanxi Cancer Hospital	Taiyuan	China	19
Shunde Hospital Of Southern Medical University	Foshan	China	3
Sun Yat-sen Memorial Hospital	Guangzhou	China	2
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The first Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	69